GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: HCP
Buy $49
down 7.00 %

HCP Inc. (NYSE: HCP) reiterated to Buy with price target $49 by Argus

Friday,  Dec 19, 2014  2:25 PM ET by Betsy O'Brien Harrison

Argus reiterated HCP Inc. (NYSE: HCP) to Buy with price target $49. Previously Argus reiterated HCP Inc. (NYSE: HCP) to Buy with price target
$54 on 03/18/2013, when the stock price was $48.52. Since then, HCP Inc.'s stock price has lost 7% as of 12/19/2014's recent price of $45.16.
If you would have followed the previous Argus's recommendation on HCP, you would have lost 7% of your investment in 641 days.

Health Care Property Investors, Inc. is a real estate investment trust. The company invests in health care related real estate located throughout the United States, including long-term care facilities, congregate care and assisted living facilities, acute care and rehabilitation hospitals, medical office buildings, physician group practice clinics and psychiatric facilities.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy